Loading clinical trials...
Loading clinical trials...
A Phase 3, an Open Clinical Trials to Evaluate Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults
Conditions
Interventions
influenza vaccine
Locations
1
Kazakhstan
Research Institute for Biological Safety Problems
Gvardeysky, Jambul, Kazakhstan
Start Date
September 18, 2017
Primary Completion Date
May 21, 2018
Completion Date
May 21, 2018
Last Updated
June 28, 2018
NCT04682444
NCT04431050
NCT02387294
NCT03448705
NCT01651104
NCT01879540
Lead Sponsor
Research Institute for Biological Safety Problems
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions